Serious games vs. traditional tutorials in the pandemic: a randomised controlled trial.
Tan SMJ, Coffey MJ, Blazek K, Sitaram N, Dobrescu I, Motta A, Chuang S and Ooi CY (2024)Â
Front. Med. 11:1424024. doi: 10.3389/fmed.2024.1424024
Â
èæ¯ã¨ç®çï¼COVID-19ã®å¤§æµè¡ã«ããããªã³ã©ã¤ã³å»å¦æè²ã¸ã®ç§»è¡ãå¿ è¦ã¨ãªã£ãã æ¬ç 究ã§ã¯ãã·ãªã¢ã¹ã²ã¼ã ã®ãã¥ã¼ããªã¢ã«[PlayMedâ¢(PM)]ãç¨ãããªã³ã©ã¤ã³çä¾ãã¼ã¹ã®ãã¥ã¼ããªã¢ã«ã®æå¹æ§ããå¾æ¥ã®ã¹ã©ã¤ãã·ã§ã¼ã®ãã¥ã¼ããªã¢ã«(TT)ã¨æ¯è¼ãã¦è©ä¾¡ããã
Â
æ¹æ³ï¼2020å¹´5æãã2021å¹´1æã¾ã§ã®COVID-19ãã³ãããã¯æéä¸ã«ãå¦é¨å»å¦çã対象ã«ååãæ··åæ³ç¡ä½çºåå¯¾ç §è©¦é¨ãå®æ½ããã å¦çã¯PM群ã¨TT群ã«ãããã¯ã©ã³ãã åãããã ãã¥ã¼ã¿ã¼ã¯ãæ°ç®¡æ¯çã¨èè ¸çã®çä¾ã«ã¤ãã¦ãPMã¾ãã¯TTãç¨ãã¦ãªã³ã©ã¤ã³æå°ãè¡ãããã¬ã¼ã³ãã¼ã·ã§ã³ãä¿é²ããã æè²çµé¨ã¯ãé£ç¶çãªåºé尺度ï¼0ï½100ï¼ãããããå®ç¾©ãããã«ãã´ãªã¼ï¼ã¨èªç±è¨è¿°ã«ããåçãç¨ãã¦è©ä¾¡ããã å³æçããã³é·æçãªç¥èã®ç¿å¾ã¯ãåçä¾ã«ã¤ãã¦6ã¤ã®å¤è¢é¸æåé¡ï¼MCQï¼ãç¨ãã¦è©ä¾¡ããï¼åè¨12MCQï¼ã PM群ã¨TT群éã®è»¢å¸°ãæ¯è¼ããããã«ãä¿®æ£intention-to-treatæ··åæ³ã¨æ度per-protocol解æãè¡ãããã
*PlayMed
- ã²ã¼ã ã®åºæ¬æ§é ï¼
- ãã¼ãã£ã«ç é¢ã§ã®å»å¸«ãã¼ã«ãã¬ã¤ã³ã°
- ã«ã¹ã¿ãã¤ãºå¯è½ãªã¢ãã¿ã¼ãä½æ
- ç é¢å ãæ©ãåããæ£è ã®è¨ºå¯ã»æ²»çãå¯è½
- é»åã«ã«ãã·ã¹ãã ã使ç¨ãã診çè¨é²
- æè²çè«ã®å¿ç¨ï¼
- Knowlesã®æ人æè²çè«ï¼ã¢ã³ãã©ã´ã¸ã¼ï¼ãæ´»ç¨
- Kolbã®çµé¨å¦ç¿çè«ãå®è£
- ã²ã¼ã ãã¶ã¤ã³çè«ï¼èªå·±æ±ºå®çè«ãMDAãã¬ã¼ã ã¯ã¼ã¯çï¼ãçµ±å
- ãã¥ã¼ããªã¢ã«ã§ã®ä½¿ç¨æ¹æ³ï¼
- æå¡ã代çãã¬ã¤ã¤ã¼ã¨ãã¦æä½
- å¦çã°ã«ã¼ãã®å¤æ°æ±ºã§è¨åºå¤æã決å®
- ãªã¢ã«ã¿ã¤ã ã§ã®ãã£ã¼ãããã¯æä¾
çµæ
å¦ç¿ä½é¨ã¸ã®å½±é¿ï¼
ãå¦ç¿æ´»åã楽ããã£ããï¼å¹æéd=0.35 (å°)
ãå¦ç¿æ´»åãé
åçã ã£ããï¼å¹æéd=0.58 (ä¸)
ããã£ã¼ãããã¯ãå¦ç¿ã«å½¹ç«ã£ããï¼å¹æéd=0.52 (ä¸)
ã対é¢ææ¥ããé
åçã ã£ããï¼å¹æéd=0.90 (大)
å¿ççå®å
¨æ§ï¼
PMã°ã«ã¼ãã§ã¯90%以ä¸ãå®å
¨ã«æããããã¨å ±å
å¿åã§ã®æ票ã·ã¹ãã ãè²¢ç®
ã¦ã§ãã«ã ã®ãªã³/ãªãé¸æå¶ã«ããå¿«é©æ§ç¢ºä¿
ç¥èç¿å¾ã¸ã®å¹æï¼
ã»æ°ç®¡æ¯çã±ã¼ã¹ï¼
PM群ãææã«é«ãã¹ã³ã¢ï¼4.1 vs 3.5, p=0.004ï¼
ç¹ã«è¨åºæè¦ã®è§£éã¨è¨ºæã«é¢ããåé¡ã§å¹æç
ã»èè ¸çã±ã¼ã¹ï¼
ã¹ã³ã¢ã«ææå·®ãªãï¼3.7 vs 3.8, p=0.7ï¼
ã±ã¼ã¹ç¹ç°çãªå¹æã®å¯è½æ§ã示å
èå¯
ã»æè²å¹æã®ã¡ã«ããºã ï¼
å®å
¨ãªç°å¢ã§ã®å¤±æçµé¨ã®æä¾
ãªã¢ã«ã¿ã¤ã ãã£ã¼ãããã¯ã®å¹æ
ã°ã«ã¼ãææ決å®ã«ããå調å¦ç¿ã®ä¿é²
ã»å¾æ¥åã¨ã®æ¯è¼åªä½ç¹ï¼
ããé«ãå¦çã®åå 度
è¨åºå¤æã®ãªã¢ã«ã¿ã¤ã ã·ãã¥ã¬ã¼ã·ã§ã³
ããå®å
¨ãªå¦ç¿ç°å¢ã®æä¾
ã»éçã¨èª²é¡ï¼
åä¸æ½è¨ã§ã®éå®çç 究
æè¡çãªåé¡ï¼æ¥ç¶æ§ãç»è³ªçï¼
é·æçãªç¥èä¿æã¸ã®å¹æãä¸æ確
ã»å°æ¥ã¸ã®ç¤ºåï¼
対é¢ææ¥ã¨ã®çµã¿åããã®å¯è½æ§
ããåºç¯ãªè¨åºã·ããªãªã¸ã®å¿ç¨
ãã«ãã»ã³ã¿ã¼è©¦é¨ã®å¿
è¦æ§
ç 究ã®é©æ°æ§
ã»ãã¥ã¼ããªã¢ã«å½¢å¼ã§ã®æ´»ç¨ï¼
ããã¾ã§ã®ç 究ã®å¤ãã¯å人ãã¬ã¤ã¤ã¼ã¾ãã¯ãã«ããã¬ã¤ã¤ã¼å½¢å¼
æå¡ä¸»å°ã®ã°ã«ã¼ãå¦ç¿ã¨ã®çµ±åã¯æ°ããã¢ããã¼ã
ã»æè²çè«ã¨ã®çµ±åï¼
è¤æ°ã®æè²çè«ã¨ã²ã¼ã çè«ã®å¹æçãªçµã¿åãã
å®è·µçãªè¨åºæ¨è«è½åã®è²æã¸ã®è²¢ç®
ã»ãã³ãããã¯å¯¾å¿ï¼
ãªã³ã©ã¤ã³å»å¦æè²ã®è³ªçåä¸ã¸ã®è²¢ç®
å¾æ¥ã®å¯¾é¢æè²ã®ä»£æ¿æ段ã¨ãã¦ã®å¯è½æ§ãå®è¨¼
Â
çµè«ï¼æ¬ç 究ã¯ãã·ãªã¢ã¹ã²ã¼ã ï¼PlayMedâ¢ï¼ãå»å¦æè²ã®ãªã³ã©ã¤ã³ææã¨ãã¦æç¨ã§ãããã¨ãå®è¨¼ããã PMã«ãããããå¦çã¯ãåªããåãçµã¿ã¨å®å ¨æã示ãã¾ããã ã¾ããã·ãªã¢ã¹ã²ã¼ã ãæ´»ç¨ãããã¨ã§ãå°ãªãã¨ãçæçã«ã¯ç¥èã®ç¿å¾ãä¿é²ãããå¯è½æ§ãããã